#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14736	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1990	732.5	0	.	n	.	0	C207T	SNP	207	207	C	472	472	T	848	T,C	421,346	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14736	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1990	732.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	827	C	780	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27026	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3520	765.3	0	.	n	.	0	T695C	SNP	695	695	T	1010	1010	C	841	C,T	778,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27026	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3520	765.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2286	2286	C	832	C	765	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27026	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3520	765.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2360	2360	A	873	A	821	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27026	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3520	765.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2912	2912	C	868	C	820	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27026	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3520	765.3	0	HET	.	.	.	A1638G	.	1638	1638	A	1953	1953	A	844	A,G	433,366	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1884	folP	855	855	100.0	folP.l15.c4.ctg.1	1557	120.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1025	1027	AGC	196;193;194	A;G;C	180;175;175	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5018	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3348	149.4	1	SNP	p	S91F	1	.	.	271	273	TTC	579	581	TTC	164;164;163	T;T,C;C	150;148,1;144	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5018	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3348	149.4	1	SNP	p	G95N	0	.	.	283	285	GGC	591	593	GGC	157;158;158	G;G;C	140;141;141	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5018	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3348	149.4	1	SNP	p	D95G	1	.	.	283	285	GGC	591	593	GGC	157;158;158	G;G;C	140;141;141	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1378	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1339	102.3	1	SNP	p	G45D	0	.	.	133	135	GGC	501	503	GGC	153;153;153	G;G;C	146;145;146	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	728	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1037	70.2	0	.	n	.	0	A197.	DEL	197	197	A	635	635	A	181	A	173	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2882	199.3	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	228;225;226	G;A;C	211;207;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2882	199.3	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	229;232;233	C;G;T	214;216;216	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2882	199.3	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	229;232;233	C;G;T	214;216;216	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2882	199.3	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	229;232;233	C;G;T	214;216;216	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2882	199.3	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	232;232;231	T;C;C	219;216;213	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3874	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2702	142.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1540	1542	GGC	189;186;185	G;G;C	179;176;174	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1196	1198	GCC	219;221;224	G;C;C	201;203;205	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1199	1201	ATG	222;222;219	A;T;G	203;201;200	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1211	1213	ACC	217;219;220	A;C;C	198;202;202	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1211	1213	ACC	217;219;220	A;C;C	198;202;202	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1712	1714	ACC	198;196;195	A;C;C	175;173;171	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1766	1768	GCG	195;196;201	G;C;G	182;183;186	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1766	1768	GCG	195;196;201	G;C;G	182;183;186	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1889	1891	GGT	176;172;172	G,T;G,T;T	162,1;158,1;156	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1898	1900	AGC	166;164;163	A;G,C;C	150;152,1;150	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3826	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	166.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1916	1918	CCG	159;159;158	C,G;C;G	120,5;123;124	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5794	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3102	186.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1702	1704	CCG	211;215;212	C;C;G	194;201;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2524	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1679	149.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	520	520	C	169	C	161	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1648	174.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	487	489	GTT	229;230;231	G;T;T	214;215;217	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1648	174.7	1	SNP	p	G120K	1	.	.	358	360	AAG	712	714	AAG	223;221;220	A,G;A,G;G,T	206,1;207,1;203,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1648	174.7	1	SNP	p	A121N	1	.	.	361	363	AAC	715	717	AAC	224;221;220	A,G;A,C;C	210,1;207,1;209	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1648	174.7	1	SNP	p	N121D	0	.	.	361	363	AAC	715	717	AAC	224;221;220	A,G;A,C;C	210,1;207,1;209	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10752	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4847	221.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1210	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1012	118.8	1	SNP	p	V57M	1	.	.	169	171	ATG	461	463	ATG	258;257;256	A;T;G,T	244;243;242,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
